|
Vinorelbine Accord 10 mg/ml koncentrát na infúzny roztok con inf 1x1 ml (liek.inj.skl.)
10 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01CA04
|
Accord Healthcare Polska Sp. z o.o. |
—
|
|
Vinorelbine Accord 10 mg/ml koncentrát na infúzny roztok con inf 1x5 ml (liek.inj.skl.)
10 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01CA04
|
Accord Healthcare Polska Sp. z o.o. |
—
|
|
Vinorelbine Glenmark 20 mg cps mol 1x20 mg (blis.Al/Al)
20 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 20 mg cps mol 1x20 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou)
20 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 20 mg cps mol 4x20 mg (blis.Al/Al)
20 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 20 mg cps mol 4x20 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou)
20 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 30 mg cps mol 1x30 mg (blis.Al/Al)
30 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 30 mg cps mol 1x30 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou)
30 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 30 mg cps mol 4x30 mg (blis.Al/Al)
30 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine Glenmark 30 mg cps mol 4x30 mg (blis.PVC/PVDC/Al s bezpeč.vrstvou)
30 mg
|
Mäkká kapsula |
L01CA04
|
Glenmark Pharmaceuticals s.r.o. |
—
|
|
Vinorelbine medac 20 mg mäkké kapsuly cps mol 1x20 mg (blis.PVC/PVDC/Al)
20 mg
|
Mäkká kapsula |
L01CA04
|
medac Gesellschaft für klinische Spezialpräparate m.b.H. |
—
|
|
Vinorelbine medac 20 mg mäkké kapsuly cps mol 4x1x20 mg (blis.PVC/PVDC/Al)
20 mg
|
Mäkká kapsula |
L01CA04
|
medac Gesellschaft für klinische Spezialpräparate m.b.H. |
—
|
|
Vinorelbine medac 30 mg mäkké kapsuly cps mol 1x30 mg (blis.PVC/PVDC/Al)
30 mg
|
Mäkká kapsula |
L01CA04
|
medac Gesellschaft für klinische Spezialpräparate m.b.H. |
—
|
|
Vinorelbine medac 30 mg mäkké kapsuly cps mol 4x1x30 mg (blis.PVC/PVDC/Al)
30 mg
|
Mäkká kapsula |
L01CA04
|
medac Gesellschaft für klinische Spezialpräparate m.b.H. |
—
|
|
Weldinin tbl flm 112x200 mg (blis.Al/PVC/PE/PVDC-kalend.)
200 mg
|
Filmom obalená tableta |
L01EX02
|
Egis Pharmaceuticals PLC |
—
|
|
Weldinin tbl flm 112x200 mg (blis.Al/PVC/PE/PVDC)
200 mg
|
Filmom obalená tableta |
L01EX02
|
Egis Pharmaceuticals PLC |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 100x500 mg (blis.Al/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 100x500 mg (blis.PVC/Aclar/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 30x500 mg (blis.Al/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 30x500 mg (blis.PVC/Aclar/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 50x500 mg (blis.Al/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 50x500 mg (blis.PVC/Aclar/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
Zassida 25 mg/ml prášok na injekčnú suspenziu plv inu 1x100 mg (liek.inj.skl.)
25 mg/1 ml
|
Prášok na injekčnú suspenziu |
L01BC07
|
Zentiva, k.s. |
—
|
|
Zassida 25 mg/ml prášok na injekčnú suspenziu plv inu 1x150 mg (liek.inj.skl.)
25 mg/1 ml
|
Prášok na injekčnú suspenziu |
L01BC07
|
Zentiva, k.s. |
—
|